Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial - Saito, H; Maruyama, I; Shimazaki, S (J Thromb Haemost, 2007)
, et al.